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Abstract
We describe a periprosthetic Brucella abortus infection in a case-patient undergoing hip 
replacement revision surgery, and the subsequent investigation of laboratory and surgical staff 
exposures. Although exposures are rare, it is important to have infection prevention 
recommendations for surgical procedures among patients with suspected or unidentified Brucella 
spp. infection.
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Brucellosis, a zoonotic disease transmitted through inhalation of infectious aerosolized 
particles, is endemic in many areas, including Mexico.(1, 2, 3, 4) Manifestations of disease 
can range from subclinical illness to osteoarticular disease and chronic sequelae.(4) It is a 
potential occupational hazard among laboratory workers.(3) Although Brucella infection is 
not usually a risk to medical staff, prosthetic joint infections have been encountered during 
surgery.(5–9) We report a case of periprosthetic Brucella infection and the subsequent 
investigation into possible transmission to operating room and laboratory staff. Objectives of 
the investigation included infection prevention, case-finding and examination into potential 
routes of Brucella spp. transmission.
Methods
The New Mexico Department of Health (NMDOH), in consultation with the Centers for 
Disease Control and Prevention (CDC) initiated an investigation of operating room and 
laboratory staff exposures. Among operating room staff, high risk exposures were defined as 
presence in the operating room during aerosol-generating procedures, including joint 
irrigation and cleaning after the procedure. NMDOH Scientific Laboratory Division and 
reference laboratory staff involved in testing the patient’s isolate were contacted to evaluate 
laboratory exposures. Serial serologic testing and antibiotic post-exposure prophylaxis 
(PEP) (100 mg doxycycline orally twice daily and rifampin 600 mg once daily for 21 days, 
for those without contraindications) was recommended for individuals with high risk 
exposures.(10) The CDC performed serological testing for anti-Brucella antibodies by 
microagglutination.
Results
The 67 year-old female patient, was born, raised in, and frequently traveled to Mexico. Her 
first hip replacement occurred in Mexico two years prior to presenting for revision. During 
the revision, implant component loosening, bone loss, and cloudy synovial fluid were noted. 
Synovial fluid was cultured, the joint debrided and copiously irrigated, and hip replacement 
was deferred; an articulating vancomycin- and tobramycin-impregnated cement spacer was 
placed. Synovial fluid was sent to a reference laboratory for bacterial culture where growth 
suggestive of Brucella spp. was recognized. The NMDOH Scientific Laboratory Division 
conducted confirmatory nucleic acid amplification testing and subsequently, the CDC 
performed speciation; Brucella abortus was identified.
Seventeen high-risk exposures and one low-risk exposure were investigated; fifteen high-
risk exposures occurred in the operating room. Personal protective equipment (PPE) varied 
from body exhaust suits (surgeon, first assistant, and scrub technician) to gloves only 
(cleaning staff); none wore N-95 respiratory protection. Since the joint was copiously 
irrigated, hospital staff who cleaned the operating room were also considered exposed. One 
low- and two high-risk exposures of reference laboratory staff occurred during isolate 
processing outside of the biosafety cabinet on an open bench; the low risk exposure occurred 
outside the five foot (1.5 m) radius qualifying as a high risk. No exposures occurred at the 
NMDOH Scientific Laboratory Division as the isolate was handled inside a biosafety 
cabinet.
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Fifteen exposed operating room staff underwent serial serologic testing and prophylaxis. 
Reference laboratory employees with high-risk exposures agreed to serologic testing but 
declined PEP. All who elected prophylaxis completed the PEP regimen. None of those 
exposed met criteria for seroconversion (i.e., fourfold increase in anti-Brucella antibody 
titer). Two individuals whose total antibody titers were indeterminate (between 1:20–1:40, 
potentially resulting from test run variation and assay cross-reaction with other antibodies) 
were referred for infectious disease consultation; no evidence of acute Brucella infection 
was detected. Exposed individuals self-monitored and were observed by personal healthcare 
or occupational medicine providers for six months; none developed symptoms of 
brucellosis.
The surgical patient was treated for three months with combination therapy (doxycycline 
and rifampin) to address osteomyelitis and prevent Brucella infection relapse. A 
preoperative aspirate, prior to re-implantation of the hip replacement, yielded a negative 
culture result. The NMDOH recommended anyone involved in re-implantation use N-95 
masks and goggles, minimize aerosol-generating procedures, and handle biological 
specimens with care. The patient’s recovery was uneventful without evidence of infection 
recurrence at the two-year follow-up.
Discussion
This case report demonstrates the need to consider evaluation for Brucella spp. infection and 
risk factors among patients with prostheses failure or osteoarticular prosthetic infections. 
Although there are not any documented instances of Brucella transmission during surgery, 
repeated instances of laboratory transmission support a precautionary approach. During 
prosthetic joint arthroplasty procedures, surgical staff may wear orthopedic space suits, or a 
mask and face shield, to protect themselves from bloodborne pathogen transmission through 
droplet sprays; further respiratory protection may be needed to protect staff from airborne 
transmission of aerosolized pathogens. As in this case, post-operative brucellosis diagnosis 
following surgery of an infected joint, warrants an evaluation of PPE appropriateness and 
potential breaches. Personnel who did not wear, or experienced a breach in PPE should be 
serologically monitored for six months and report new symptoms consistent with 
brucellosis. PEP may be considered if the procedure aerosolized the Brucella organism.
If preoperative patient evaluation identifies Brucella spp. infection, appropriate antibiotic 
therapy can be initiated to decrease bacterial load in surrounding tissues, and precautions 
taken to limit surgical Brucella spp. exposure. Surgeons and operating room staff should 
wear appropriate respiratory PPE (i.e. N95 mask), minimize aerosol-generating procedures, 
and only essential operating room personnel should be present. Regardless of PPE worn, 
personnel present during the procedure should be considered for six months of symptom 
monitoring, because of potential unrecognized aerosol exposures and PPE breaches.
Although rare in those countries where it is nonendemic, brucellosis osteoarticular infections 
occur and pose a potential risk to surgeons and other operating room staff. Therefore, 
recommendations similar to the guidelines for accidental Brucella spp. laboratory are 
needed to standardize PPE usage, prevent transmission of brucellosis during surgical 
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procedures, and provide follow-up regarding symptom and serologic monitoring, and 
administration of PEP.
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